Indication
ASC-US
3 clinical trials
4 products
Clinical trial
Phase I Clinical Trial Assessing the Safety and Feasibility of Intramuscular pNGVL4aCRTE6E7L2 and TA-CIN Administration for the Treatment of Patients With Persistent HPV16+ ASC-US or LSILStatus: Recruiting, Estimated PCD: 2024-06-30
Product
pNGVL4aCRTE6E7L2Product
TA-CINClinical trial
Interventional Study on Efficacy of Lactobacillus Crispatus M247 in Patients Affected by HPV Low-grade Preneoplastic Cervical Lesions and Evaluation of Vaginal Microbiota Changes Before and After Oral SupplementationStatus: Recruiting, Estimated PCD: 2023-02-02
Product
Lactobacillus Crispatus M247Clinical trial
A Randomized Double-Blind, Placebo-controlled Phase II Trial With Safety Run-In of Intramuscular pNGVL4a-Sig/E7(Detox)/HSP70 and TA-CIN for the Treatment of Patients With HPV16+ Atypical Squamous Cells of Undetermined Significance (ASC-US) or Cannot Exclude High Grade SIL (ASC-H) Cytology or Low-grade Squamous Intraepithelial Lesion (LSIL)Status: Terminated, Estimated PCD: 2022-06-08
Product
PVX-2